iDose® TR helps patients with glaucoma take longterm control of high eye pressureLAGUNA HILLS, CA / ACCESSWIRE / February 20, 2024 / Harvard Eye Associates is proud to announce the availability of iDose® TR travoprost intraocular implant 75 mcg. iDose® TR is a new, FDAapproved treatment that is designed to provide longduration, continuous drug therapy directly inside the eye,... Lire le communiqué |